Meyer I, Westhoff A, Meyer-Lindenberg A, Bubeck B, Nolte I
Klinik für kleine Haustiere, Tierärztlichen Hochschule Hannover.
Berl Munch Tierarztl Wochenschr. 1997 May;110(5):185-9.
In the presented study 99mTc-MAG3 clearance measurements were undertaken in 14 dogs during renal scintigraphic examination. Of these dogs, 10 showed no renal impairment, the other 4 exhibited clinically manifested nephropathy. It was the aim of these examinations to determine if this type of clearance measurement that is routinely used in human medicine is suitable for diagnosis of canine nephropathy. An algorithm for the calculation of the MAG3-Clearance developed for humans was modified. The clearance measurement can be performed during the renal scintigraphic procedure without any difficulties. In the group of dogs with no renal impairment the clearance values ranged between 6.4 and 8.0 ml/min/kg, whereas in the group of patients exhibiting nephropathies the values ranged between 2.0 and 2.7 ml/min/kg. The suitability of the method for its use in dogs needs to be confirmed with higher patient numbers. In addition, further studies are necessary to precisely assess the correlation between measured clearance values and effective renal plasma flow in dogs.
在本研究中,对14只犬进行肾脏闪烁扫描检查时测定了99mTc-MAG3清除率。在这些犬中,10只未表现出肾脏损伤,另外4只表现出临床表现的肾病。这些检查的目的是确定这种在人类医学中常规使用的清除率测量方法是否适用于犬肾病的诊断。为人类开发的计算MAG3清除率的算法进行了修改。清除率测量可在肾脏闪烁扫描过程中顺利进行。在无肾脏损伤的犬组中,清除率值在6.4至8.0毫升/分钟/千克之间,而在患有肾病的犬组中,值在2.0至2.7毫升/分钟/千克之间。该方法在犬类中的适用性需要通过更多病例数来证实。此外,还需要进一步研究以精确评估犬类中测量的清除率值与有效肾血浆流量之间的相关性。